Emanuel E Canfora
Overview
Explore the profile of Emanuel E Canfora including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
2460
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Larik G, Canfora E, van Schothorst E, Blaak E
Cell Host Microbe
. 2024 Aug;
32(8):1225-1229.
PMID: 39146794
Microbial fermentation and associated products provide insights into the gut microbiota-host relationship. Here, we propose using improved technologies that allow non-invasive, real-time measurements of intestinal gases as a metric for...
2.
Canfora E, Feitelson M, Arzumanyan A
Front Microbiol
. 2023 Sep;
14:1270001.
PMID: 37771705
No abstract available.
3.
Canfora E, Vliex L, Wang T, Nauta A, Bouwman F, Holst J, et al.
Front Nutr
. 2023 Aug;
10:1200645.
PMID: 37529001
Background: Infusion of short-chain fatty acids (SCFA) to the distal colon beneficially affects human substrate and energy metabolism. Here, we hypothesized that the combination of 2'-fucosyllactose (2'-FL) with resistant starch...
4.
van Deuren T, Smolders L, Hartog A, Bouwman F, Holst J, Venema K, et al.
Front Nutr
. 2023 Jan;
9:1066950.
PMID: 36687671
Background: Short chain fatty acids (SCFA) are increasingly recognized for their potential ability to alleviate obesity-associated chronic low-grade inflammation and disturbed energy homeostasis. Evidence suggests that an increase in circulating...
5.
van Deuren T, Blaak E, Canfora E
Obes Rev
. 2022 Jul;
23(10):e13498.
PMID: 35856338
Evidence is increasing that disturbances in the gut microbiome may play a significant role in the etiology of obesity and type 2 diabetes. The short chain fatty acid butyrate, a...
6.
Girdhar K, Soto M, Huang Q, Orliaguet L, Cederquist C, Sundaresh B, et al.
Diabetes
. 2022 Feb;
71(5):945-960.
PMID: 35212729
Growing evidence indicates an important link between gut microbiota, obesity, and metabolic syndrome. Alterations in exocrine pancreatic function are also widely present in patients with diabetes and obesity. To examine...
7.
Jardon K, Canfora E, Goossens G, Blaak E
Gut
. 2022 Feb;
71(6):1214-1226.
PMID: 35135841
Accumulating evidence indicates that the gut microbiome is an important regulator of body weight, glucose and lipid metabolism, and inflammatory processes, and may thereby play a key role in the...
8.
Canfora E, Hermes G, Muller M, Bastings J, Vaughan E, van den Berg M, et al.
Gut Microbes
. 2021 Dec;
14(1):2009297.
PMID: 34923911
Infusions of the short-chain fatty acid (SCFA) acetate in the distal colon improved metabolic parameters in men. Here, we hypothesized that combining rapidly and slowly fermentable fibers will enhance distal...
9.
Gonzalez Hernandez M, Blaak E, Hoebers N, Essers Y, Canfora E, Jocken J
Front Endocrinol (Lausanne)
. 2021 Jul;
12:659928.
PMID: 34220709
Our recent human studies showed that colonic administration of sodium acetate (SA) resulted in increased circulating acetate levels, which was accompanied by increments in whole-body fat oxidation in overweight-obese men....
10.
Canfora E, Blaak E
Nat Rev Endocrinol
. 2020 Sep;
16(11):613-614.
PMID: 32887950
No abstract available.